INS and diabetes mellitus: HCV eradication through antiviral therapy reduces hepatic complications and leads to improved metabolic outcomes [6, 7, 8], potentially reducing insulin resistance, enhancing beta‐cell function [9, 10], and reducing the incidence of diabetes [8].